This study is aimed at identifying the epistatic effects and haplotypes of GAS5, miR-146a, its target IRAK-1, and miR-155 SNPs concerning the susceptibility to MS and its subtypes. This evidence concerns the gene GAS5 and myeloid sarcoma.